Evidence map›Paper›PMID 28329761›Full record

ArticleNature2017

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.

Young Seok Ju, Inigo Martincorena, Moritz Gerstung, Mia Petljak, Ludmil B Alexandrov, Raheleh Rahbari, David C Wedge, Helen R Davies, Manasa Ramakrishna, Anthony Fullam and 31 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 2 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 2 syntheses or guidelines pooled it, 300 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Reconstruction of Cell Diversity and Cell Lineages from Somatic Mutations in Single-Cell Transcriptomic Data.DNA research : an international journal for rapid publication of reports on genes and genomes · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Genome degradation in plant tissue culture.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Disease insights from brain somatic mosaicism.Experimental & molecular medicine · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Inferring Cell Differentiation Dynamics with Unobserved Progenitors.bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. Clonal dynamics of monozygotic twinning in early human embryogenesis.bioRxiv : the preprint server for biology · 2025
    Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 11 countries.

Young Seok JuCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Inigo MartincorenaCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Moritz GerstungCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Mia PetljakCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Ludmil B AlexandrovCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Raheleh RahbariGenomic Mutation and Genetic Disease, Wellcome Trust Sanger Institute, Hinxton, UK.
David C WedgeCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Helen R DaviesCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Manasa RamakrishnaCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Anthony FullamCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Sancha MartinCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Christopher AlderCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Nikita PatelCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Steve GambleCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Sarah O'MearaCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Dilip D GiriDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Torril SauerInstitute of Clinical Medicine, Campus at Akershus University Hospital, University of Oslo, Lørenskog, Norway.
Sarah E PinderKing's Health Partners Cancer Biobank, Guy's Hospital, King's College London School of Medicine, London, UK.
Colin A PurdieDepartment of Pathology, Ninewells Hospital and Medical School, Dundee, UK.
Åke BorgBioCare, Strategic Cancer Research Program, Lund, Sweden.
Henk StunnenbergRadboud University Medical Center, Nijmegen, The Netherlands.
Marc van de VijverDepartment of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
Benita K T TanSingHealth Duke-NUS Breast Centre, Division of Surgical Oncology, National Cancer Centre Singapore, Department of General Surgery, Singapore General Hospital, Singapore.
Carlos CaldasCancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.
Andrew TuttBreast Cancer Now Research Unit, King's College London, London SE1 9RT, UK.
Naoto T UenoDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Laura J van 't VeerDepartment of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.
John W M MartensDepartment of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Christos SotiriouInstitut Jules Bordet, Brussels, Belgium.
Stian KnappskogSection of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.
Paul N SpanDepartment of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Sunil R LakhaniUniversity of Queensland, School of Medicine, Brisbane, Australia.
Jórunn Erla EyfjördCancer Research Laboratory, University of Iceland, Reykjavik, Iceland.
Anne-Lise Børresen-DaleDepartment of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.
Andrea RichardsonSibley Pathology Department, Johns Hopkins Medicine, Washington DC 20016, USA.
Alastair M ThompsonDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Alain ViariPlateforme Gilles Thomas, Synergie Lyon Cancer, Centre Léon Bérard, Lyon Cedex 08, France.
Matthew E HurlesGenomic Mutation and Genetic Disease, Wellcome Trust Sanger Institute, Hinxton, UK.
Serena Nik-ZainalCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Peter J CampbellCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Michael R StrattonCancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Wellcome Sanger Institute · GBKing's College London · GBRadboud University Medical Center · NLThe University of Texas MD Anderson Cancer Center · USUniversity of Oslo · NOAcademic Medical Center · NLCancer Research UK Cambridge Center · GBCentre for Human Genetics · GBCentre Léon Bérard · FRErasmus MC Cancer Institute · NLHaukeland University Hospital · NOInstitut Jules Bordet · BEJohns Hopkins Medicine · USKorea Advanced Institute of Science and Technology · KRLund University · SEMemorial Sloan Kettering Cancer Center · USNinewells Hospital · GBSingHealth · SGUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of Iceland · IS

Funding

Cancer Research UK 16942Cancer Research UK 21777Wellcome TrustWellcome Trust 077012/Z/05/Z
6 · The paper itself

Abstract

Somatic cells acquire mutations throughout the course of an individual's life. Mutations occurring early in embryogenesis are often present in a substantial proportion of, but not all, cells in postnatal humans and thus have particular characteristics and effects. Depending on their location in the genome and the proportion of cells they are present in, these mosaic mutations can cause a wide range of genetic disease syndromes and predispose carriers to cancer. They have a high chance of being transmitted to offspring as de novo germline mutations and, in principle, can provide insights into early human embryonic cell lineages and their contributions to adult tissues. Although it is known that gross chromosomal abnormalities are remarkably common in early human embryos, our understanding of early embryonic somatic mutations is very limited. Here we use whole-genome sequences of normal blood from 241 adults to identify 163 early embryonic mutations. We estimate that approximately three base substitution mutations occur per cell per cell-doubling event in early human embryogenesis and these are mainly attributable to two known mutational signatures. We used the mutations to reconstruct developmental lineages of adult cells and demonstrate that the two daughter cells of many early embryonic cell-doubling events contribute asymmetrically to adult blood at an approximately 2:1 ratio. This study therefore provides insights into the mutation rates, mutational processes and developmental outcomes of cell dynamics that operate during early human embryogenesis.

Indexed as

MutationAdultBlood CellsCell LineageEmbryo, MammalianEmbryonic DevelopmentGenome, HumanGerm-Line MutationHumansMosaicismMutagenesisMutation Rate

Identifiers

PMID28329761
PMCPMC6169740
OpenAlexW2603764892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.